4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-006988
Chief Executive Officer acquired 332,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-02 | Grant or award : show line 1 in the form | +332,500 | 934,964 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-02 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +617,500 | 1,836,875 | D |
Loading xslF345X03/doc4.xml…